Company: MBIO
Filing Date: 2025-01-22
Form Type: DEF 14C
Source: 0001104659-25-005251
Chunk: 4

Company: MUSTANG BIO, INC.
Filing Date: 2025-01-22
Form: DEF 14C
Chunk 4
---
 and we assume no obligation to update any such forward-looking
statements. Our business and financial performance are subject to substantial risks and uncertainties. Actual results could differ materially
from those projected in the forward-looking statements.

<div align='center'>RECORD DATE AND VOTE REQUIRED</div>

The close of business on
January 14, 2025 has been fixed as the Record Date. As of January 14, 2025, we had (i) 64,768,830 shares of our common stock outstanding
and entitled to vote, (ii) 845,385 shares of our Class A common stock, par value $0.0001 per share (“Class A Common Stock”),
outstanding and entitled to vote, and (iii) 250,000 shares of our Class A Preferred Stock outstanding and entitled to vote. Each share
of common stock and Class A Common Stock is entitled to one vote on each matter to be voted upon at a meeting or via written consent.

Each share of Class A Preferred
Stock is entitled to the number of votes that is equal to one and one-tenth times a fraction, the numerator of which is the sum of (A)
the shares of outstanding common stock and (B) the whole shares of common stock into which the shares of outstanding Class A Common Stock
and Class A Preferred Stock are convertible and the denominator of which is the number of shares of outstanding Class A Preferred Stock.
As of the Record Date, there were a total of 136,151,230 votes outstanding (64,768,830 common stock votes plus 56,359 Class A Common
Stock votes plus 71,326,041 Class A Preferred Stock votes).

Pursuant to Section 228 of
the DGCL, unless otherwise provided in the certificate of incorporation, any corporate action required to be taken at a meeting of stockholders
may be taken without a meeting, without prior notice and without a vote, if a consent or consents in writing, setting forth the action
so taken, shall be signed by stockholders having not less than the minimum number of votes that would be necessary to authorize or take
such action at a meeting at which all members having a right to vote thereon were present and voted. The Majority Holders, who held in
the aggregate the equivalent of 77,878,822 votes, or approximately 57% of the voting equity of the Company, voted in favor of the Warrant
Share Issuance by executing the Written Consent in lieu of a